Inhaled Remimazolam Potentiates Inhaled Remifentanil in Rodents

被引:37
作者
Bevans, Tatjana [1 ]
Deering-Rice, Cassandra [2 ]
Stockmann, Chris [3 ]
Rower, Joseph [3 ]
Sakata, Derek [1 ]
Reilly, Christopher [2 ]
机构
[1] Univ Utah, Dept Anesthesiol, Room 3C444 SOM,30 N 1900 E, Salt Lake City, UT 84132 USA
[2] Univ Utah, Dept Pharmacol & Toxicol, Room 3C444 SOM,30 N 1900 E, Salt Lake City, UT 84132 USA
[3] Univ Utah, Dept Pediat, Room 3C444 SOM,30 N 1900 E, Salt Lake City, UT 84132 USA
关键词
MONITORED ANESTHESIA CARE; CHOLINERGIC NEUROTRANSMISSION; MIDAZOLAM; MICE; OPIOIDS; AIRWAYS; HYPERRESPONSIVENESS; PHARMACODYNAMICS; PHARMACOKINETICS; DYSPNEA;
D O I
10.1213/ANE.0000000000002022
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: Remimazolam is an ester-based short-acting benzodiazepine currently in clinical trials for IV administration. This study explored the feasibility of delivering remimazolam alone and as an adjunct to remifentanil via inhalation in rodent models. METHODS: Mice were exposed to remimazolam via inhalation; sedation was assessed using time to movement outside a set perimeter. Rats were also exposed to remimazolam aerosol alone and in combination with inhaled remifentanil, and analgesia was quantified by using a tail flick meter. Pulmonary injury was assessed in mice using mechanics measurements. RESULTS: Mice showed significantly increased time to movement outside a set perimeter after 5-minute exposure to increasing concentrations (10-25 mg/mL solutions) of inhaled remimazolam aerosols. Differences in mean (95% confidence interval) time to movement from pretest baseline group (0.05 [0.01-0.09] minutes) were 11 (4-18), 15 (5-26), 30 (19-41), and 109 (103-115) minutes after exposure to remimazolam aerosol of 10, 15, 20, and 25 mg/mL, respectively (P = .007 P < .0001). Exposure of rats to remimazolam aerosols alone failed to produce sedation or analgesia after a 5-minute exposure. When remimazolam (10 or 25 mg/mL) was administered in combination with 250 tg/mL remifentanil, there was a significant difference in time to tail flick (P < .0001) consistent with a strong analgesic effect. Mean (95% confidence interval) differences in time to tail flick from the pretest baseline group (3.2 [2.5-3.9] seconds) were 14 (10-18) seconds when 250 mu g/mL remifentanil was administered with either 10 or 25 mg/mL remimazolam. Remimazolam alone or in combination with remifentanil did not cause lung irritation, bronchospasm, or other adverse pulmonary events to the respiratory tract of mice as assessed by Flexi-Vent pulmonary function tests. CONCLUSIONS: Remimazolam can significantly potentiate the analgesic effect of remifentanil when concurrently delivered via inhalation.
引用
收藏
页码:1484 / 1490
页数:7
相关论文
共 19 条
  • [1] Acid aspiration-induced airways hyperresponsiveness in mice
    Allen, Gilman B.
    Leclair, Timothy R.
    von Reyn, Jessica
    Larrabee, Yuna C.
    Cloutier, Mary E.
    Irvin, Charles G.
    Bates, Jason H. T.
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2009, 107 (06) : 1763 - 1770
  • [2] A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics
    Antonik, Laurie J.
    Goldwater, D. Ronald
    Kilpatrick, Gavin J.
    Tilbrook, Gary S.
    Borkett, Keith M.
    [J]. ANESTHESIA AND ANALGESIA, 2012, 115 (02) : 274 - 283
  • [3] Interactions between midazolam and remifentanil during monitored anesthesia care
    Avramov, MN
    Smith, I
    White, PF
    [J]. ANESTHESIOLOGY, 1996, 85 (06) : 1283 - 1289
  • [4] ENDOGENOUS OPIOIDS MODULATE THE INCREASE IN VENTILATORY OUTPUT AND DYSPNEA DURING SEVERE ACUTE BRONCHOCONSTRICTION
    BELLOFIORE, S
    DIMARIA, GU
    PRIVITERA, S
    SAPIENZA, S
    MILICEMILI, J
    MISTRETTA, A
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (04): : 812 - 816
  • [5] MODULATION OF CHOLINERGIC NEUROTRANSMISSION IN GUINEA-PIG AIRWAYS BY OPIOIDS
    BELVISI, MG
    STRETTON, CD
    BARNES, PJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (01) : 131 - 137
  • [6] INHIBITION OF CHOLINERGIC NEUROTRANSMISSION IN HUMAN AIRWAYS BY OPIOIDS
    BELVISI, MG
    STRETTON, CD
    VERLEDEN, GM
    LEDINGHAM, SJL
    YACOUB, MH
    BARNES, PJ
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1992, 72 (03) : 1096 - 1100
  • [7] Inhaled Remifentanil in Rodents
    Bevans, Tatjana
    Deering-Rice, Cassandra
    Stockmann, Chris
    Light, Alan
    Reilly, Christopher
    Sakata, Derek J.
    [J]. ANESTHESIA AND ANALGESIA, 2016, 122 (06) : 1831 - 1838
  • [8] D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
  • [9] Seizure protection by intrapulmonary delivery of midazolam in mice
    Dhir, Ashish
    Zolkowska, Dorota
    Rogawski, Michael A.
    [J]. NEUROPHARMACOLOGY, 2013, 73 : 425 - 431
  • [10] Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care
    Gold, MI
    Watkins, WD
    Sung, YF
    Yarmush, J
    Chung, F
    Uy, NT
    Maurer, W
    Clarke, MY
    Jamerson, BD
    [J]. ANESTHESIOLOGY, 1997, 87 (01) : 51 - 57